While patients receiving adrenocorticotrophic hormone (ACTH) often show an increased sense of well-being and mild euphoria, a small number become psychotic. Electroencephalographic (EEG) changes ( 1 ) have been reported in patients receiving ACTH who become psychotic, but the changes have been inconsistently present. In one instance (2) the EEG changes appeared to be related to a decrease in serum potassium level.
While patients receiving adrenocorticotrophic hormone (ACTH) often show an increased sense of well-being and mild euphoria, a small number become psychotic. Electroencephalographic (EEG) changes ( 1 ) have been reported in patients receiving ACTH who become psychotic, but the changes have been inconsistently present. In one instance (2) the EEG changes appeared to be related to a decrease in serum potassium level.
These observations led to a study of cerebral blood flow and metabolism in patients receiving ACTH. Concurrent investigation of the EEG (3) and of the clinical and metabolic responses of these subjects will be reported elsewhere (4) . METHOD A total of 44 observations on 14 patients was made; 15 All of the patients were studied under similar laboratory conditions in the fasting state. The nitrous oxide method originally described by Kety and Schmidt (5) and modified by Scheinberg and Stead (6) was used. The gas mixture used in the determination consisted of approximately 15% N20, 64% N2, and 21% 0. Arterial blood pressure was measured by the auscultatory method with the arm held at heart level. Mean arterial blood pressures were calculated from these readings by adding one third of the pulse pressure to the diastolic pressure. Blood samples for determination of oxygen and glucose contents were drawn just before and following each cerebral blood flow. The A-V oxygen difference was determined by the method described by Hickam and Frayser (7) . The blood glucose content was measured by Nelson's (8) photometric adaptation of the Somogyi method. Cerebral oxygen and glucose utilizations were calculated as previously described (5, 6) .
RESULTS
The results summarized in Table I show a statistically significant decrease in cerebral blood flow on ACTH treatment from 61 to 50 ml./min./100 gm. brain. After approximately 14 days on therapy no further decrease in cerebral blood flow oc- however, a 32% increase in cerebral vascular resistance (CVR) since the decrease in cerebral blood flow was greater than the rise in mean arterial blood pressure. Six patients with normal or high pre-treatment cerebral blood flows had studies performed both before initiation and after discontinuation of ACTH therapy. In this group there was only a 3 ml./ min./100 gm. brain difference and thus the before and after flows have been grouped together in the column labeled "No ACTH" in Table I .
There were six patients included in Table I whose cerebral blood flow before ACTH therapy was below 50 ml./min./100 gm. brain. These patients also showed low oxygen and glucose consumption by the brain. In these six patients ACTH treatment was not associated with further reduction in cerebral blood flow (46 to 45 ml./ min./100 gm. brain), nor was oxygen consumption (2.8 to 2.9 ml. O/min./100 gm. brain) significantly altered. Although these patients did develop a similar slight hypertension as did the group with normal initial flows, no significant change in cerebral vascular resistance occurred. The clinical response to ACTH treatment was similar regardless of the original level of cerebral blood flow.
Two patients were studied before, during and following a psychotic episode which developed during ACTH therapy. These studies were not different from the cerebral blood flow changes which occurred in other patients receiving ACTH who did not become psychotic. Thus psychotic behavior during ACTH therapy was not associated with change in cerebral metabolism as measured by this method. Serial EEG studies were done on all patients (3). In 12 there was no gross change in the EEG pattern, including the two patients who had tracings during their period of psychosis. Definite improvement in EEG pattern was found on therapy in two patients. There appeared to be no correlation between changes in cerebral blood flow and EEG patterns. Nor was it possible to correlate changes in plasma carbon dioxide combining power or serum potassium levels with changes in either cerebral blood flow or mental status.
DISCUSSION
The results show ACTH significantly decreased cerebral blood flow without changing cerebral oxygen and glucose consumption. This response. occurs before or by the end of the second week of therapy, and seems to persist unchanged as long as the therapy is continued. The effect is reversible in that cerebral blood flow returns to pre-treatment levels within a few days after discontinuation of treatment with ACTH. In patients with abnormally low pre-treatment cerebral blood flow ACTH did not change either cerebral blood flow or cerebral metabolism.
How ACTH decreases cerebral blood flow is unknown. The decrease in cerebral blood flow could be related to generalized increase in peripheral resistance, to a decrease in cardiac output, or to a localized increase in resistance in the cerebral circulation. The rise in arterial pressure is less than would be expected if the peripheral resistance as a whole had increased to the same extent as the resistance in the cerebral vessels. In fragmentary preliminary studies, ACTH has not consistently changed cardiac output (9) (10) (11) . Horwitz and colleagues have reported that the cardiac output frequently decreases in those instances in which ACTH produces a fall in heart rate. The best explanation from the available data is a local increase in cerebral vascular resistance of unknown etiology.
A reduction in cerebral blood flow out of proportion to the general increase in peripheral resistance has been observed in subjects breathing 85%b oxygen and during hyperventilation (12) .
The cerebral metabolism of oxygen and glucose is normally maintained by simultaneous and adequate widening of their respective A-V differences.
It is well known that cerebral vessels are extremely sensitive to changes in blood pH (12) 2. An 18% decrease in cerebral blood flow occurred during ACTH therapy. This was associated with a 32%o increase in cerebral vascular resistance and 9%o increase in mean arterial blood pressure. These changes were accompanied by significant widening of arterial-cerebral venous oxygen and glucose differences, and hence no change in cerebral metabolic utilization of oxygen or glucose.
3. The decrease in cerebral blood flow during ACTH treatment occurs before or by the end of the second week, apparently persists unchanged on continued therapy, and returns to pre-treatment levels within several days after discontinuing ACTH. 4 . No information was found by this method to explain either the sense of well-being or the psychotic episodes which occur during ACTH therapy.
